From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

“I don’t want people to presume that this Trump presidency will be bad for PR,” Edelman told PRWeek. “I think there will be ...

Cytokinetics is hoping to launch a drug targeting a chronic heart condition next year but while it waits on regulatory ...

California this year took the final step in opening Medi-Cal, its Medicaid program, to every eligible resident regardless of ...

Nearly three years ago, these jurisdictions signed an agreement promising annual reports “specifying the activities and ...

The campaign is titled Artful Ingenuity, which shares its initials with artificial intelligence, and underscores Eversana ...

Community health worker programs are spreading across the U.S., including in rural areas and small cities as health providers ...

Vermonters pay the highest prices nationwide for individual health coverage, and state reports show its providers and ...

A new federal watchdog audit is ratcheting up pressure on government officials to crack down on billions of dollars in overcharges linked to Medicare Advantage home visits.

Havas is to offer key staff up to €37.5 million (£31.5 million/$40.3 million) in share awards as part of its Dutch stock market listing, following its planned separation from parent company Vivendi in ...

Voters backed abortion rights in seven of the 10 states where the issue appeared on ballots Tuesday. Voters backed abortion ...

Only 13 states currently offer Medicaid coverage for GLP-1 drugs, but the number of prescriptions and overall spending has ...